Brief: Interpace Biosciences Q3 Revenue USD 9.078 Million
08/11/2023 20:29
Nov 08 (Reuters) - Interpace Biosciences Q3 operating expenses USD 4.97 million. * Q3 net income USD -614 thousand * Q3 gross profit USD 4.954 million * Q3 operating income USD -16 thousand
Recent news on Interpace Biosciences
See all newsBrief: Interpace Biosciences Announces Reverse Stock Split To Support Proposed Nasdaq Uplisting
Interpace Biosciences Q2 revenue falls despite growth in thyroid business
Brief: Interpace Biosciences Q2 Revenue USD 9.131 Million
Interpace Biosciences Q1 revenue falls
Brief: Interpace Biosciences Q1 Revenue USD 9.032 Million